Literature DB >> 18037120

Scleritis and peripheral ulcerative keratitis.

Anat Galor1, Jennifer E Thorne.   

Abstract

Scleritis and peripheral ulcerative keratitis (PUK) can present as isolated conditions or as part of a systemic inflammatory or infectious disorder. Both are serious ocular conditions that can result in vision loss and require early diagnosis and treatment. Nearly two thirds of patients with non-infectious scleritis require systemic glucocorticoid therapy and one fourth need a glucocorticoid-sparing agent as well. Essentially all patients with non-infectious PUK require systemic glucocorticoids. A detailed clinical history, thorough physical examination, and thoughtful laboratory evaluations are important in the exclusion of underlying disorders and extraocular involvement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037120      PMCID: PMC2212596          DOI: 10.1016/j.rdc.2007.08.002

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  42 in total

1.  Episcleritis and scleritis: clinical features and treatment results.

Authors:  D A Jabs; A Mudun; J P Dunn; M J Marsh
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

2.  Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients.

Authors:  P J McCluskey; P G Watson; S Lightman; J Haybittle; M Restori; M Branley
Journal:  Ophthalmology       Date:  1999-12       Impact factor: 12.079

3.  Successful treatment of Wegener's granulomatosis associated scleritis with rituximab.

Authors:  C M G Cheung; P I Murray; C O S Savage
Journal:  Br J Ophthalmol       Date:  2005-11       Impact factor: 4.638

4.  Rheumatic disease and scleritis.

Authors:  Anat Galor; Jennifer E Thorne; Douglas A Jabs
Journal:  Ophthalmology       Date:  2007-06       Impact factor: 12.079

Review 5.  Therapy insight: scleritis and its relationship to systemic autoimmune disease.

Authors:  Justine R Smith; Friederike Mackensen; James T Rosenbaum
Journal:  Nat Clin Pract Rheumatol       Date:  2007-04

6.  Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia.

Authors:  Sanjay R Kedhar; Marie-Lyne Belair; Albert S Jun; Mark Sulkowski; Jennifer E Thorne
Journal:  Arch Ophthalmol       Date:  2007-06

7.  Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.

Authors:  Anat Galor; Victor L Perez; Jeffrey P Hammel; Careen Y Lowder
Journal:  Ophthalmology       Date:  2006-09-25       Impact factor: 12.079

Review 8.  Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection.

Authors:  M R Dana; Y Qian; P Hamrah
Journal:  Cornea       Date:  2000-09       Impact factor: 2.651

9.  Incidence of corneal melting in association with systemic disease in the Yorkshire Region, 1995-7.

Authors:  M McKibbin; J D Isaacs; A J Morrell
Journal:  Br J Ophthalmol       Date:  1999-08       Impact factor: 4.638

10.  [Successful treatment of a patient with refractory Wegener's granulomatosis by rituximab].

Authors:  Rumi Minami; Tomoya Miyamura; Hideyuki Watanabe; Soichiro Takahama; Masahiro Yamamoto; Eiichi Suematsu
Journal:  Nihon Rinsho Meneki Gakkai Kaishi       Date:  2007-04
View more
  33 in total

Review 1.  Ocular vasculitis.

Authors:  Gabriela M Espinoza; Ankit Desai; Levent Akduman
Journal:  Curr Rheumatol Rep       Date:  2013-09       Impact factor: 4.592

2.  Peripheral ulcerative keratitis: a serious complication of rheumatoid arthritis.

Authors:  Bruno L Silva; Juliana B Cardozo; Patrícia Marback; Felipe Carrhá Machado; Verena Galvão; Mittermayer B Santiago
Journal:  Rheumatol Int       Date:  2009-10-13       Impact factor: 2.631

Review 3.  Ocular and orbital pain for the headache specialist.

Authors:  Alexander L Ringeisen; Andrew R Harrison; Michael S Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2011-04       Impact factor: 5.081

4.  Tear-mediated delivery of nanoparticles through transcytosis of the lacrimal gland.

Authors:  Pang-Yu Hsueh; Maria C Edman; Guoyong Sun; Pu Shi; Shi Xu; Yi-An Lin; Honggang Cui; Sarah F Hamm-Alvarez; J Andrew MacKay
Journal:  J Control Release       Date:  2014-12-16       Impact factor: 9.776

5.  Ocular Inflammation in the Setting of Concomitant Systemic Autoimmune Conditions in an Older Male Population.

Authors:  Alexandra E Levitt; Katherine T McManus; Allison L McClellan; Janet L Davis; Raquel Goldhardt; Anat Galor
Journal:  Cornea       Date:  2015-07       Impact factor: 2.651

Review 6.  [Diseases of the outer eye in rheumatoid arthritis].

Authors:  E Feist; U Pleyer
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

7.  [Ophthalmological findings as a hint for systemic disease].

Authors:  W A Herrmann; H Helbig; M A Gamulescu
Journal:  Internist (Berl)       Date:  2010-04       Impact factor: 0.743

Review 8.  Headaches attributed to visual disturbances.

Authors:  S Bianchi Marzoli; A Criscuoli
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

Review 9.  Ocular inflammatory diseases associated with rheumatoid arthritis.

Authors:  Mathieu Artifoni; Pierre-Raphaël Rothschild; Antoine Brézin; Loïc Guillevin; Xavier Puéchal
Journal:  Nat Rev Rheumatol       Date:  2013-12-10       Impact factor: 20.543

Review 10.  [Typical questions from the rheumatologist to the ophthalmologist and cooperating radiologist].

Authors:  B Nölle; M Both; M Heller; J B Roider
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.